{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:35:24Z","timestamp":1779377724922,"version":"3.53.1"},"reference-count":82,"publisher":"Bentham Science Publishers Ltd.","issue":"5","funder":[{"DOI":"10.13039\/100013133","name":"Defense and Veterans Brain Injury Center","doi-asserted-by":"publisher","award":["Sec721 NDAA FY2007"],"award-info":[{"award-number":["Sec721 NDAA FY2007"]}],"id":[{"id":"10.13039\/100013133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAR"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n<jats:title>Background::<\/jats:title>\n<jats:p>Traumatic brain injury (TBI) has been associated with increased likelihood of late-life dementia; however, the mechanisms driving this relationship are elusive. Blood-based biomarkers may provide insight into these mechanisms and serve as useful prognostic indicators of cognitive recovery or decline following a TBI.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The aim of this study was to examine blood biomarkers within one year of TBI and explore their relationship with cognitive decline.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Service members and veterans (n=224) without injury (n=77), or with history of bodily injury (n=37), uncomplicated mild TBI (n=55), or more severe TBI (n=55), underwent a blood draw and neuropsychological assessment within one year of their injury as part of a case-control study. A subsample (n=87) completed follow-up cognitive assessment.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>In the more severe TBI group, baseline glial fibrillary acidic protein (p=.008) and ubiquitin C-terminal hydrolase-L1 (p=.026) were associated with processing speed at baseline, and baseline ubiquitin C-terminal hydrolase-L1 predicted change in immediate (R2\u0394=.244, p=.005) and delayed memory (R2\u0394=.390, p=.003) over time. In the mild TBI group, higher baseline tau predicted greater negative change in perceptual reasoning (R2\u0394=.188, p=.033) and executive functioning (R2\u0394=.298, p=.007); higher baseline neurofilament light predicted greater negative change in perceptual reasoning (R2\u0394=.211, p=.012).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Baseline ubiquitin C-terminal hydrolase-L1 strongly predicted memory decline in the more severe TBI group, while tau and neurofilament light strongly predicted decline in the mild TBI group. A panel including these biomarkers could be particularly helpful in identifying those at risk for future cognitive decline following TBI.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567205019666220330144432","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T09:20:12Z","timestamp":1648804812000},"page":"351-363","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Blood Biomarkers Predict Future Cognitive Decline after Military-Related\nTraumatic Brain Injury"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6352-7577","authenticated-orcid":true,"given":"Sara M.","family":"Lippa","sequence":"first","affiliation":[{"name":"National Intrepid Center of Excellence, Walter Reed National Military Medical Center, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Gill","sequence":"additional","affiliation":[{"name":"National Institutes of Health, National Institute of Nursing Research, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey A.","family":"Brickell","sequence":"additional","affiliation":[{"name":"National Intrepid Center of Excellence, Walter Reed National Military Medical Center, Bethesda, MD, USA"},{"name":"Defense and Veterans Brain Injury Center, Walter Reed National Military Medical Center, Bethesda, MD, USA"},{"name":"Contractor, General Dynamics Information Technology, Falls Church, VA, USA"},{"name":"Uniformed Services University of the Health Sciences, Bethesda, MD, USA"},{"name":"Centre of Excellence on Post-traumatic Stress Disorder, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian A.","family":"Guedes","sequence":"additional","affiliation":[{"name":"National Institutes of Health, National Institute of Nursing Research, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M.","family":"French","sequence":"additional","affiliation":[{"name":"National Intrepid Center of Excellence, Walter Reed National Military Medical Center, Bethesda, MD, USA"},{"name":"Defense and Veterans Brain Injury Center, Walter Reed National Military Medical Center, Bethesda, MD, USA"},{"name":"Uniformed Services University of the Health Sciences, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rael T.","family":"Lange","sequence":"additional","affiliation":[{"name":"National Intrepid Center of Excellence, Walter Reed National Military Medical Center, Bethesda, MD, USA"},{"name":"Defense and Veterans Brain Injury Center, Walter Reed National Military Medical Center, Bethesda, MD, USA"},{"name":"Contractor, General Dynamics Information Technology, Falls Church, VA, USA"},{"name":"Centre of Excellence on Post-traumatic Stress Disorder, Ottawa, ON, Canada"},{"name":"University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"Jack C.R.","year":"2013","unstructured":"Jack C.R.; Knopman D.S.; Jagust W.J.; Tracking pathophysiological processes in Alzheimer\u2019s disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurol 2013,12(2),207-216","journal-title":"Lancet Neurol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.neubiorev.2021.07.007","volume":"128","author":"Qu Y.","year":"2021","unstructured":"Qu Y.; Ma Y.H.; Huang Y.Y.; Blood biomarkers for the diagnosis of amnestic mild cognitive impairment and Alzheimer\u2019s disease: A systematic review and meta-analysis. Neurosci Biobehav Rev 2021,128,479-486","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=3","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12447","author":"Chatterjee P.","year":"2021","unstructured":"Chatterjee P.; Pedrini S.; Ashton N.J.; Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer\u2019s disease. Alzheimers Dement Epub ahead of print2021","journal-title":"Alzheimers Dement"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3233\/JAD-180325","volume":"67","author":"Oeckl P.","year":"2019","unstructured":"Oeckl P.; Halbgebauer S.; Anderl-Straub S.; Glial Fibrillary acidic protein in serum is increased in alzheimer\u2019s disease and correlates with cognitive impairment. J Alzheimers Dis 2019,67(2),481-488","journal-title":"J Alzheimers Dis"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13195-020-00682-7","volume":"12","author":"Verberk I.M.W.","year":"2020","unstructured":"Verberk I.M.W.; Thijssen E.; Koelewijn J.; Combination of plasma amyloid beta and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology. Alzheimers Res Ther 2020,12(1),118","journal-title":"Alzheimers Res Ther"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e12921","DOI":"10.15252\/emmm.202012921","volume":"12","author":"Su\u00e1rez-Calvet M.","year":"2020","unstructured":"Su\u00e1rez-Calvet M.; Karikari T.K.; Ashton N.J.; Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer\u2019s continuum when only subtle changes in A\u03b2 pathology are detected. EMBO Mol Med 2020,12(12),e12921","journal-title":"EMBO Mol Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/brain\/awaa399","volume":"144","author":"Moscoso A.","year":"2021","unstructured":"Moscoso A.; Grothe M.J.; Ashton N.J.; Time course of phosphorylated-tau181 in blood across the Alzheimer\u2019s disease spectrum. Brain 2021,144(1),325-339","journal-title":"Brain"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"Karikari T.K.","year":"2020","unstructured":"Karikari T.K.; Pascoal T.A.; Ashton N.J.; Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: A diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol 2020,19(5),422-433","journal-title":"Lancet Neurol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/jamaneurol.2020.4986","volume":"78","author":"Moscoso A.","year":"2021","unstructured":"Moscoso A.; Grothe M.J.; Ashton N.J.; Longitudinal associations of blood phosphorylated tau181 and neurofilament light chain with neurodegeneration in Alzheimer disease. JAMA Neurol 2021,78(4),396-406","journal-title":"JAMA Neurol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","volume":"141","author":"Ashton N.J.","year":"2021","unstructured":"Ashton N.J.; Pascoal T.A.; Karikari T.K.; Plasma p-tau231: A new biomarker for incipient Alzheimer\u2019s disease pathology. Acta Neuropathol 2021,141(5),709-724","journal-title":"Acta Neuropathol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1001\/jamaneurol.2018.0815","volume":"75","author":"Barnes D.E.","year":"2018","unstructured":"Barnes D.E.; Byers A.L.; Gardner R.C.; Seal K.H.; Boscardin W.J.; Yaffe K.; Association of mild traumatic brain injury with and without loss of consciousness with dementia in us military veterans. JAMA Neurol 2018,75(9),1055-1061","journal-title":"JAMA Neurol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3233\/JAD-143207","volume":"47","author":"Mendez M.F.","year":"2015","unstructured":"Mendez M.F.; Paholpak P.; Lin A.; Zhang J.Y.; Teng E.; Prevalence of traumatic brain injury in early versus late-onset Alzheimer\u2019s disease. J Alzheimers Dis 2015,47(4),985-993","journal-title":"J Alzheimers Dis"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/ana.24101","volume":"75","author":"Nordstr\u00f6m P.","year":"2014","unstructured":"Nordstr\u00f6m P.; Micha\u00eblsson K.; Gustafson Y.; Nordstr\u00f6m A.; Traumatic brain injury and young onset dementia: A nationwide cohort study. Ann Neurol 2014,75(3),374-381","journal-title":"Ann Neurol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/jnnp.74.7.857","volume":"74","author":"Fleminger S.","year":"2003","unstructured":"Fleminger S.; Oliver D.L.; Lovestone S.; Rabe-Hesketh S.; Giora A.; Head injury as a risk factor for Alzheimer\u2019s disease: The evidence 10 years on; a partial replication. J Neurol Neurosurg Psychiatry 2003,74(7),857-862","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1212\/WNL.54.6.1316","volume":"54","author":"Guo Z.","year":"2000","unstructured":"Guo Z.; Cupples L.A.; Kurz A.; Head injury and the risk of AD in the MIRAGE study. Neurology 2000,54(6),1316-1323","journal-title":"Neurology"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1212\/WNL.55.8.1158","volume":"55","author":"Plassman B.L.","year":"2000","unstructured":"Plassman B.L.; Havlik R.J.; Steffens D.C.; Documented head injury in early adulthood and risk of Alzheimer\u2019s disease and other dementias. Neurology 2000,55(8),1158-1166","journal-title":"Neurology"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.expneurol.2004.06.011","volume":"190","author":"Ikonomovic M.D.","year":"2004","unstructured":"Ikonomovic M.D.; Uryu K.; Abrahamson E.E.; Alzheimer\u2019s pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol 2004,190(1),192-203","journal-title":"Exp Neurol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"907","DOI":"10.2174\/15672050113109990142","volume":"10","author":"Veitch D.P.","year":"2013","unstructured":"Veitch D.P.; Friedl K.E.; Weiner M.W.; Military risk factors for cognitive decline, dementia and Alzheimer\u2019s disease. Curr Alzheimer Res 2013,10(9),907-930","journal-title":"Curr Alzheimer Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1742-2094-11-82","volume":"11","author":"Turtzo L.C.","year":"2014","unstructured":"Turtzo L.C.; Lescher J.; Janes L.; Dean D.D.; Budde M.D.; Frank J.A.; Macrophagic and microglial responses after focal traumatic brain injury in the female rat. J Neuroinflammation 2014,11,82","journal-title":"J Neuroinflammation"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.forsciint.2004.06.027","volume":"146","author":"Gentleman S.M.","year":"2004","unstructured":"Gentleman S.M.; Leclercq P.D.; Moyes L.; Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int 2004,146(2-3),97-104","journal-title":"Forensic Sci Int"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.2174\/1567205013666160222110320","volume":"13","author":"Djordjevic J.","year":"2016","unstructured":"Djordjevic J.; Sabbir M.G.; Albensi B.C.; Traumatic brain injury as a risk factor for Alzheimer\u2019s disease: Is inflammatory signaling a key player? Curr Alzheimer Res 2016,13(7),730-738","journal-title":"Curr Alzheimer Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/neu.2013.3040","volume":"31","author":"Diaz-Arrastia R.","year":"2014","unstructured":"Diaz-Arrastia R.; Wang K.K.; Papa L.; Acute biomarkers of traumatic brain injury: Relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J Neurotrauma 2014,31(1),19-25","journal-title":"J Neurotrauma"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1212\/WNL.0b013e318253d5c7","volume":"78","author":"Metting Z.","year":"2012","unstructured":"Metting Z.; Wilczak N.; Rodiger L.A.; Schaaf J.M.; van der Naalt J.; GFAP and S100B in the acute phase of mild traumatic brain injury. Neurology 2012,78(18),1428-1433","journal-title":"Neurology"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.annemergmed.2011.08.021","volume":"59","author":"Papa L.","year":"2012","unstructured":"Papa L.; Lewis L.M.; Falk J.L.; Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Ann Emerg Med 2012,59(6),471-483","journal-title":"Ann Emerg Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1089\/neu.2015.4333","volume":"34","author":"Bogoslovsky T.","year":"2017","unstructured":"Bogoslovsky T.; Wilson D.; Chen Y.; Increases of plasma levels of glial fibrillary acidic protein, tau, and amyloid \u03b2 up to 90 Days after traumatic brain injury. J Neurotrauma 2017,34(1),66-73","journal-title":"J Neurotrauma"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1212\/WNL.0000000000003912","volume":"88","author":"Shahim P.","year":"2017","unstructured":"Shahim P.; Zetterberg H.; Tegner Y.; Blennow K.; Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports. Neurology 2017,88(19),1788-1794","journal-title":"Neurology"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"36791","DOI":"10.1038\/srep36791","volume":"6","author":"Shahim P.","year":"2016","unstructured":"Shahim P.; Gren M.; Liman V.; Serum neurofilament light protein predicts clinical outcome in traumatic brain injury. Sci Rep 2016,6,36791","journal-title":"Sci Rep"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"e000433","DOI":"10.1136\/bmjsem-2018-000433","volume":"4","author":"Wallace C.","year":"2018","unstructured":"Wallace C.; Smirl J.D.; Zetterberg H.; Heading in soccer increases serum neurofilament light protein and SCAT3 symptom metrics. BMJ Open Sport Exerc Med 2018,4(1),e000433","journal-title":"BMJ Open Sport Exerc Med"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1089\/neu.2015.4295","volume":"33","author":"Oliver J.M.","year":"2016","unstructured":"Oliver J.M.; Jones M.T.; Kirk K.M.; Serum neurofilament light in american football athletes over the course of a season. J Neurotrauma 2016,33(19),1784-1789","journal-title":"J Neurotrauma"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"e1780","DOI":"10.1212\/WNL.0000000000005518","volume":"90","author":"Shahim P.","year":"2018","unstructured":"Shahim P.; Tegner Y.; Marklund N.; Blennow K.; Zetterberg H.; Neurofilament light and tau as blood biomarkers for sports-related concussion. Neurology 2018,90(20),e1780-e1788","journal-title":"Neurology"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/neu.2015.3949","volume":"33","author":"Korley F.K.","year":"2016","unstructured":"Korley F.K.; Diaz-Arrastia R.; Wu A.H.; Circulating brain-derived neurotrophic factor has diagnostic and prognostic value in traumatic brain injury. J Neurotrauma 2016,33(2),215-225","journal-title":"J Neurotrauma"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1177\/1545968315600525","volume":"30","author":"Failla M.D.","year":"2016","unstructured":"Failla M.D.; Juengst S.B.; Arenth P.M.; Wagner A.K.; Preliminary associations between brain-derived neurotrophic factor, memory impairment, functional cognition, and depressive symptoms following severe TBI. Neurorehabil Neural Repair 2016,30(5),419-430","journal-title":"Neurorehabil Neural Repair"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1097\/00005072-199708000-00009","volume":"56","author":"Nag S.","year":"1997","unstructured":"Nag S.; Takahashi J.L.; Kilty D.W.; Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. J Neuropathol Exp Neurol 1997,56(8),912-921","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fneur.2019.00246","volume":"10","author":"Sandsmark D.K.","year":"2019","unstructured":"Sandsmark D.K.; Bogoslovsky T.; Qu B.X.; Changes in plasma von willebrand factor and cellular fibronectin in MRI-defined traumatic microvascular injury. Front Neurol 2019,10,246","journal-title":"Front Neurol"},{"key":"ref=35","unstructured":"FDA Decision Memorandum. Evaluation of automatic class III designation for benyon brain trauma indicator. 2018."},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1080\/02699052.2018.1471738","volume":"32","author":"Gill J.","year":"2018","unstructured":"Gill J.; Mustapic M.; Diaz-Arrastia R.; Higher exosomal tau, amyloid-beta 42 and IL-10 are associated with mild TBIs and chronic symptoms in military personnel. Brain Inj 2018,32(10),1277-1284","journal-title":"Brain Inj"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3389\/fnins.2019.01005","volume":"13","author":"Winston C.N.","year":"2019","unstructured":"Winston C.N.; Romero H.K.; Ellisman M.; Assessing neuronal and astrocyte derived exosomes from individuals with mild traumatic brain injury for markers of neurodegeneration and cytotoxic activity. Front Neurosci 2019,13,1005","journal-title":"Front Neurosci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1080\/02699052.2018.1483530","volume":"32","author":"Kenney K.","year":"2018","unstructured":"Kenney K.; Qu B.X.; Lai C.; Higher exosomal phosphorylated tau and total tau among veterans with combat-related repetitive chronic mild traumatic brain injury. Brain Inj 2018,32(10),1276-1284","journal-title":"Brain Inj"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1089\/neu.2018.6269","volume":"36","author":"Lippa S.M.","year":"2019","unstructured":"Lippa S.M.; Yeh P.H.; Gill J.; French L.M.; Brickell T.A.; Lange R.T.; Plasma tau and amyloid are not reliably related to injury characteristics, neuropsychological performance, or white matter integrity in service members with a history of traumatic brain injury. J Neurotrauma 2019,36(14),2190-2199","journal-title":"J Neurotrauma"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1001\/jamaneurol.2015.1383","volume":"72","author":"Olivera A.","year":"2015","unstructured":"Olivera A.; Lejbman N.; Jeromin A.; Peripheral total tau in military personnel who sustain traumatic brain injuries during deployment. JAMA Neurol 2015,72(10),1109-1116","journal-title":"JAMA Neurol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/jts.22418","volume":"32","author":"Pattinson C.L.","year":"2019","unstructured":"Pattinson C.L.; Gill J.M.; Lippa S.M.; Brickell T.A.; French L.M.; Lange R.T.; Concurrent mild traumatic brain injury and posttraumatic stress disorder is associated with elevated tau concentrations in peripheral blood plasma. J Trauma Stress 2019,32(4),546-554","journal-title":"J Trauma Stress"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/HTR.0000000000000485","volume":"35","author":"Pattinson C.L.","year":"2020","unstructured":"Pattinson C.L.; Shahim P.; Taylor P.; Elevated tau in military personnel relates to chronic symptoms following traumatic brain injury. J Head Trauma Rehabil 2020,35(1),66-73","journal-title":"J Head Trauma Rehabil"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1038\/s41380-020-0674-z","volume":"26","author":"Dickstein D.L.","year":"2020","unstructured":"Dickstein D.L.; De Gasperi R.; Gama Sosa M.A.; Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure. Mol Psychiatry 2020,26(10),5940-5954","journal-title":"Mol Psychiatry"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"e2412","DOI":"10.1212\/WNL.0000000000009577","volume":"94","author":"Guedes V.A.","year":"2020","unstructured":"Guedes V.A.; Kenney K.; Shahim P.; Exosomal neurofilament light: A prognostic biomarker for remote symptoms after mild traumatic brain injury? Neurology 2020,94(23),e2412-e2423","journal-title":"Neurology"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1177\/0963689717714098","volume":"26","author":"Devoto C.","year":"2017","unstructured":"Devoto C.; Arcurio L.; Fetta J.; Inflammation relates to chronic behavioral and neurological symptoms in military personnel with traumatic brain injuries. Cell Transplant 2017,26(7),1169-1177","journal-title":"Cell Transplant"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.psychres.2019.07.001","volume":"279","author":"Kanefsky R.","year":"2019","unstructured":"Kanefsky R.; Motamedi V.; Mithani S.; Mysliwiec V.; Gill J.M.; Pattinson C.L.; Mild traumatic brain injuries with loss of consciousness are associated with increased inflammation and pain in military personnel. Psychiatry Res 2019,279,34-39","journal-title":"Psychiatry Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"e1126","DOI":"10.1212\/WNL.0000000000010087","volume":"95","author":"Peltz C.B.","year":"2020","unstructured":"Peltz C.B.; Kenney K.; Gill J.; Diaz-Arrastia R.; Gardner R.C.; Yaffe K.; Blood biomarkers of traumatic brain injury and cognitive impairment in older veterans. Neurology 2020,95(9),e1126-e1133","journal-title":"Neurology"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3233\/JAD-151028","volume":"51","author":"Stern R.A.","year":"2016","unstructured":"Stern R.A.; Tripodis Y.; Baugh C.M.; Preliminary study of plasma exosomal tau as a potential biomarker for chronic traumatic encephalopathy. J Alzheimers Dis 2016,51(4),1099-1109","journal-title":"J Alzheimers Dis"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1089\/neu.2019.6831","volume":"37","author":"Asken B.M.","year":"2020","unstructured":"Asken B.M.; Yang Z.; Xu H.; Acute effects of sport-related concussion on serum glial fibrillary acidic protein, ubiquitin C-terminal hydrolase L1, total tau, and neurofilament light measured by a multiplex assay. J Neurotrauma 2020,37(13),1537-1545","journal-title":"J Neurotrauma"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"761","DOI":"10.4103\/neuroindia.NI_884_15","volume":"65","author":"Dey S.","year":"2017","unstructured":"Dey S.; Gangadharan J.; Deepika A.; Correlation of ubiquitin C terminal hydrolase and S100\u03b2 with cognitive deficits in young adults with mild traumatic brain injury. Neurol India 2017,65(4),761-766","journal-title":"Neurol India"},{"key":"ref=51","author":"Lippa S.M.","year":"2020","unstructured":"Lippa S.M.; Gill J.; Brickell T.A.; French L.M.; Lange R.T.;  Blood biomarkers relate to cognitive performance years after traumatic brain injury in service members and veterans 2020","journal-title":"Blood biomarkers relate to cognitive performance years after traumatic brain injury in service members and veterans"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/jts.22480","volume":"33","author":"Lange R.T.","year":"2020","unstructured":"Lange R.T.; French L.M.; Lippa S.M.; Bailie J.M.; Brickell T.A.; Posttraumatic stress disorder is a stronger predictor of long-term neurobehavioral outcomes than traumatic brain injury severity. J Trauma Stress 2020,33(3),318-329","journal-title":"J Trauma Stress"},{"key":"ref=53","first-page":"1","author":"Lange R.T.","year":"2019","unstructured":"Lange R.T.; Lippa S.M.; French L.M.; Long-term neurobehavioural symptom reporting following mild, moderate, severe, and penetrating traumatic brain injury in U.S. military service members. Neuropsychol Rehabil 2019,1-24","journal-title":"Neuropsychol Rehabil"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1089\/neu.2019.6696","volume":"37","author":"Lippa S.M.","year":"2020","unstructured":"Lippa S.M.; French L.M.; Bell R.S.; Brickell T.A.; Lange R.T.; United States military service members demonstrate substantial and heterogeneous long-term neuropsychological dysfunction after moderate, severe, and penetrating traumatic brain injury. J Neurotrauma 2020,37(4),608-617","journal-title":"J Neurotrauma"},{"key":"ref=55","author":"Wechsler D.","unstructured":"Wechsler D.;  Wechsler Adult Intelligence Scale-Fourth Edition: Technical and interpretive manual. San Antonio, TX: Pearson 2008."},{"key":"ref=56","author":"Wechsler D.","unstructured":"Wechsler D.;  Wechsler Memory Scale-Fourth Edition: Technical and interpretive manual. San Antonio, TX: Pearson 2009."},{"key":"ref=57","author":"Delis D.C.","year":"2000","unstructured":"Delis D.C.; Kramer J.H.; Kaplan E.; Ober B.A.;  California Verbal Learning Test 2000","journal-title":"California Verbal Learning Test"},{"key":"ref=58","author":"Delis D.C.","year":"2001","unstructured":"Delis D.C.; Kaplan E.; Kramer J.H.;  Delis-Kaplan Executive Functioning System (D-KEFS): Examiner\u2019s manual 2001","journal-title":"Delis-Kaplan Executive Functioning System (D-KEFS): Examiner\u2019s manual"},{"key":"ref=59","author":"Heaton R.K.","year":"2004","unstructured":"Heaton R.K.; Miller S.W.; Taylor M.J.; Grant I.;  Revised Comprehensive Norms for an Expanded Halstead Reitan Battery: Demographically Adjusted Neuropsychological Nroms for African American and Caucasian Adults 2004","journal-title":"Revised Comprehensive Norms for an Expanded Halstead Reitan Battery: Demographically Adjusted Neuropsychological Nroms for African American and Caucasian Adults"},{"key":"ref=60","year":"2009","unstructured":"Pearson Advanced clinical solutions for use with WAIS-IV and WMS-IV 2009","journal-title":"Pearson Advanced clinical solutions for use with WAIS-IV and WMS-IV"},{"key":"ref=61","author":"Green P.","year":"2004","unstructured":"Green P.;  Green\u2019s Medical Symptom Validity Test (MSVT) for Microsoft Windows: User\u2019s manual 2004","journal-title":"Green\u2019s Medical Symptom Validity Test (MSVT) for Microsoft Windows: User\u2019s manual"},{"key":"ref=62","author":"Tombaugh T.N.","year":"1996","unstructured":"Tombaugh T.N.;  TOMM: Test of Memory Malingering 1996","journal-title":"TOMM: Test of Memory Malingering"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","volume":"87","author":"Mattsson N.","year":"2016","unstructured":"Mattsson N.; Zetterberg H.; Janelidze S.; Plasma tau in Alzheimer disease. Neurology 2016,87(17),1827-1835","journal-title":"Neurology"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/jamaneurol.2017.1359","volume":"74","author":"Mielke M.M.","year":"2017","unstructured":"Mielke M.M.; Hagen C.E.; Wennberg A.M.V.; Association of plasma total tau level with cognitive decline and risk of mild cognitive impairment or dementia in the mayo clinic study on aging. JAMA Neurol 2017,74(9),1073-1080","journal-title":"JAMA Neurol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"e610","DOI":"10.1212\/WNL.0000000000009983","volume":"95","author":"Shahim P.","year":"2020","unstructured":"Shahim P.; Politis A.; van der Merwe A.; Neurofilament light as a biomarker in traumatic brain injury. Neurology 2020,95(6),e610-e622","journal-title":"Neurology"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"e623","DOI":"10.1212\/WNL.0000000000009985","volume":"95","author":"Shahim P.","year":"2020","unstructured":"Shahim P.; Politis A.; van der Merwe A.; Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI. Neurology 2020,95(6),e623-e636","journal-title":"Neurology"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2174\/1567205015666180110120026","volume":"15","author":"Becker R.E.","year":"2018","unstructured":"Becker R.E.; Greig N.H.; Lahiri D.K.; (-)-Phenserine and inhibiting pre-programmed cell death: In pursuit of a novel intervention for Alzheimer\u2019s disease. Curr Alzheimer Res 2018,15(9),883-891","journal-title":"Curr Alzheimer Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"104528","DOI":"10.1016\/j.nbd.2019.104528","volume":"130","author":"Lecca D.","year":"2019","unstructured":"Lecca D.; Bader M.; Tweedie D.; (-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer\u2019s disease challenged mice. Neurobiol Dis 2019,130,104528","journal-title":"Neurobiol Dis"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/14737159.2018.1428089","volume":"18","author":"Wang K.K.","year":"2018","unstructured":"Wang K.K.; Yang Z.; Zhu T.; An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Mol Diagn 2018,18(2),165-180","journal-title":"Expert Rev Mol Diagn"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/TA.0b013e3182491e3d","volume":"72","author":"Papa L.","year":"2012","unstructured":"Papa L.; Lewis L.M.; Silvestri S.; Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention. J Trauma Acute Care Surg 2012,72(5),1335-1344","journal-title":"J Trauma Acute Care Surg"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"275 Pt 3(03): 305-15","DOI":"10.1016\/j.expneurol.2015.03.020","author":"Burda JE","year":"2016","unstructured":"Burda JE; Bernstein AM; Sofroniew MV; Astrocyte roles in traumatic brain injury. Experimental neurology 2016,275 Pt 3(03): 305-15","journal-title":"Experimental neurology"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ceb.2015.02.004","volume":"32","author":"Hol E.M.","year":"2015","unstructured":"Hol E.M.; Pekny M.; Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr Opin Cell Biol 2015,32,121-130","journal-title":"Curr Opin Cell Biol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/B978-0-444-52892-6.00004-0","volume":"127","author":"Mckee A.C.","year":"2015","unstructured":"Mckee A.C.; Daneshvar D.H.; The neuropathology of traumatic brain injury. Handb Clin Neurol 2015,127,45-66","journal-title":"Handb Clin Neurol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1523\/JNEUROSCI.2469-20.2020","volume":"41","author":"Witcher K.G.","year":"2021","unstructured":"Witcher K.G.; Bray C.E.; Chunchai T.; Traumatic brain injury causes chronic cortical inflammation and neuronal dysfunction mediated by microglia. J Neurosci 2021,41(7),1597-1616","journal-title":"J Neurosci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","volume":"90","author":"Gaetani L.","year":"2019","unstructured":"Gaetani L.; Blennow K.; Calabresi P.; Di Filippo M.; Parnetti L.; Zetterberg H.; Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry 2019,90(8),870-881","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/s41467-021-22114-2","volume":"12","author":"Weinhofer I.","year":"2021","unstructured":"Weinhofer I.; Rommer P.; Zierfuss B.; Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy. Nat Commun 2021,12(1),1816","journal-title":"Nat Commun"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrneurol.2013.9","volume":"9","author":"Zetterberg H.","year":"2013","unstructured":"Zetterberg H.; Smith D.H.; Blennow K.; Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nat Rev Neurol 2013,9(4),201-210","journal-title":"Nat Rev Neurol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"7963","DOI":"10.1073\/pnas.1812413116","volume":"116","author":"Reinicke A.T.","year":"2019","unstructured":"Reinicke A.T.; Laban K.; Sachs M.; Ubiquitin C-terminal hydrolase L1 (UCH-L1) loss causes neurodegeneration by altering protein turnover in the first postnatal weeks. Proc Natl Acad Sci USA 2019,116(16),7963-7972","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/cne.24577","volume":"527","author":"Kubo A.","year":"2019","unstructured":"Kubo A.; Misonou H.; Matsuyama M.; Distribution of endogenous normal tau in the mouse brain. J Comp Neurol 2019,527(5),985-998","journal-title":"J Comp Neurol"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/B978-0-12-802395-2.00025-0","volume":"Vol. 145","author":"Kovacs G.G.","year":"2018","unstructured":"Kovacs G.G.;  Chapter 25 - Tauopathies Handbook of Clinical Neurology 2018,Vol. 145,355-368","journal-title":"Chapter 25 - Tauopathies Handbook of Clinical Neurology"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1091\/mbc.E19-03-0183","volume":"30","author":"Iwata M.","year":"2019","unstructured":"Iwata M.; Watanabe S.; Yamane A.; Miyasaka T.; Misonou H.; Regulatory mechanisms for the axonal localization of tau protein in neurons. Mol Biol Cell 2019,30(19),2441-2457","journal-title":"Mol Biol Cell"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/NEN.0000000000000030","volume":"73","author":"Ferrer I.","year":"2014","unstructured":"Ferrer I.; L\u00f3pez-Gonz\u00e1lez I.; Carmona M.; Glial and neuronal tau pathology in tauopathies: Characterization of disease-specific phenotypes and tau pathology progression. J Neuropathol Exp Neurol 2014,73(1),81-97","journal-title":"J Neuropathol Exp Neurol"}],"container-title":["Current Alzheimer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567205019666220330144432","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/202857\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567205019666220330144432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T21:30:44Z","timestamp":1691789444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/202857\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567205019666220330144432","relation":{},"ISSN":["1567-2050"],"issn-type":[{"value":"1567-2050","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-11-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}